Livesense Inc. (6054.T)
JPY 130.0
(2.36%)
JPY 130.0
(2.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.2 Million | 731.03 Million | -361 Million | -1.99 Billion | 255.85 Million | 135.67 Million |
| Net Income | 716.22 Million | 424.93 Million | -950.27 Million | -1.1 Billion | 1.77 Billion | 288.09 Million |
| Depreciation & Amortization | 3.28 Million | 1.8 Million | - | 25.77 Million | 34.98 Million | 42.47 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -420.32 Million | 106.59 Million | 89.57 Million | -231.25 Million | 24.26 Million | -26.04 Million |
| Other non-cash items | -291.98 Million | 197.69 Million | 499.68 Million | -677.88 Million | -1.57 Billion | -168.85 Million |
| Investing Cash Flow | 84.87 Million | 128.83 Million | 19.34 Million | -12.45 Million | 1.72 Billion | -53.31 Million |
| Investments in PPE | -9.14 Million | - | - | -8.16 Million | -16.22 Million | -15.91 Million |
| Acquisitions | - | - | - | - | 1.75 Billion | -38 Million |
| Investment purchases | - | - | - | - | -8.36 Million | - |
| Sales/Maturities of investments | 94.02 Million | - | - | - | 9 Million | - |
| Other Investing Activities | 1000.00 | 128.83 Million | 19.34 Million | -4.29 Million | -7.66 Million | 595 Thousand |
| Financing Cash Flow | -4.9 Million | -4.9 Million | 15 Million | -197.57 Million | 14.78 Million | 79.12 Million |
| Debt repayment | -4.9 Million | -24.5 Million | -14.7 Million | -14.7 Million | -14.7 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -207.5 Million | - | - |
| Common Stock Issuance | - | - | 302 Thousand | 129 Thousand | 86 Thousand | 129 Thousand |
| Other Financing Activities | - | 19.6 Million | 29.4 Million | 49 Million | 29.4 Million | 79 Million |
| Accounts receivables | -59.46 Million | -27.1 Million | 73.93 Million | 6 Million | 50.82 Million | 56.35 Million |
| Accounts payables | - | 27.1 Million | - | - | - | -3.48 Million |
| Inventory | -269.83 Million | -25.16 Million | - | - | - | 1.93 Million |
| Other working capital | -91.03 Million | 131.76 Million | 15.64 Million | -237.25 Million | -26.55 Million | -27.97 Million |
| Cash at beginning of period | 3.56 Billion | 2.7 Billion | 3.03 Billion | 5.23 Billion | 3.23 Billion | 3.07 Billion |
| Cash at end of period | 3.64 Billion | 3.56 Billion | 2.7 Billion | 3.03 Billion | 5.23 Billion | 3.23 Billion |
| Capital Expenditure | -9.14 Million | - | - | -8.16 Million | -16.22 Million | -15.91 Million |
| Effect of forex changes on cash | 1000.00 | 1000.00 | 1000.00 | -2000.00 | 1000.00 | - |
| Net cash flow / Change in cash | 87.17 Million | 854.97 Million | -326.66 Million | -2.2 Billion | 1.99 Billion | 161.48 Million |
| Free Cash Flow | -1.94 Million | 731.03 Million | -361 Million | -1.99 Billion | 239.62 Million | 119.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 143 Million | 134 Million | 716.22 Million | 247 Million | 178 Million | 218 Million |
| Depreciation & Amortization | - | - | 3.28 Million | 1.09 Million | 1.07 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -420.32 Million | - | - | - |
| Other non-cash items | -143 Million | -134 Million | -291.98 Million | -247 Million | -178 Million | -218 Million |
| Investing Cash Flow | - | - | 84.87 Million | - | - | - |
| Investments in PPE | - | - | -9.14 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 94.02 Million | - | - | - |
| Other Investing Activities | - | - | 1000.00 | - | - | - |
| Financing Cash Flow | - | - | -4.9 Million | - | - | - |
| Debt repayment | - | - | -4.9 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | -59.46 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -269.83 Million | - | - | - |
| Other working capital | - | - | -91.03 Million | - | - | - |
| Cash at beginning of period | - | - | 3.56 Billion | 3.55 Billion | 3.45 Billion | 3.46 Billion |
| Cash at end of period | - | - | 3.64 Billion | 3.64 Billion | 3.55 Billion | 3.45 Billion |
| Capital Expenditure | - | - | -9.14 Million | - | - | - |
| Effect of forex changes on cash | - | - | 1000.00 | - | - | - |
| Net cash flow / Change in cash | - | - | 87.17 Million | 90.78 Million | 105.38 Million | -17.17 Million |
| Free Cash Flow | - | - | -1.94 Million | 2.18 Million | 2.15 Million | - |
8511
KIT
IBDRY
069620
TCRRF
KHRNF